These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37199428)

  • 1. Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in Regular Users.
    Liyanage M; Nikanjam M; Capparelli EV; Suhandynata RT; Fitzgerald RL; Marcotte TD; Grant I; Momper JD
    Ther Drug Monit; 2023 Oct; 45(5):689-696. PubMed ID: 37199428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cannabidiol in cannabis flower: Implications for harm reduction.
    Gibson LP; Karoly HC; Ellingson JM; Klawitter J; Sempio C; Squeri JE; Bryan AD; Bidwell LC; Hutchison KE
    Addict Biol; 2022 Jan; 27(1):e13092. PubMed ID: 34467598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial.
    Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Sobolesky PM; Smith BE; Hoffman MA; Hubbard JA; Severson J; Huestis MA; Grant I; Fitzgerald RL
    JAMA Psychiatry; 2022 Mar; 79(3):201-209. PubMed ID: 35080588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Population Pharmacokinetic Modeling to Estimate Exposure to Δ9-Tetrahydrocannabinol in an Observational Study of Cannabis Smokers in Colorado.
    Sempio C; Bidwell LC; Hutchison K; Huestis MA; Klawitter J; Christians U; Henthorn TK
    Ther Drug Monit; 2021 Aug; 43(4):536-545. PubMed ID: 33656464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled Δ9-Tetrahydrocannabinol Cannabis Market Products in Occasional and Daily Users.
    Henthorn TK; Wang GS; Dooley G; Brooks-Russell A; Wrobel J; Limbacher S; Kosnett M
    Ther Drug Monit; 2024 Oct; 46(5):672-680. PubMed ID: 39235358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
    Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
    Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
    Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
    J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect Compartment Model for the Evaluation of Tolerance to Psychological Highness Following Smoking Marijuana.
    Singla S; Block R
    J Clin Pharmacol; 2022 Dec; 62(12):1539-1547. PubMed ID: 35692186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulated driving performance among daily and occasional cannabis users.
    Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
    Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
    Goullé JP; Guerbet M
    Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model.
    Hunault CC; van Eijkeren JC; Mensinga TT; de Vries I; Leenders ME; Meulenbelt J
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):148-53. PubMed ID: 20450927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
    Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
    Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
    Huestis MA; Barnes A; Smith ML
    Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacological characterization of Cannabis sativa chemovar extracts.
    Devsi A; Kiyota B; Ouellette T; Hegle AP; Rivera-Acevedo RE; Wong J; Dong Y; Pugsley MK; Fung T
    J Cannabis Res; 2020 May; 2(1):17. PubMed ID: 33526117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.
    Hubbard JA; Hoffman MA; Ellis SE; Sobolesky PM; Smith BE; Suhandynata RT; Sones EG; Sanford SK; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    J Anal Toxicol; 2021 Sep; 45(8):820-828. PubMed ID: 34185831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
    Klumpers LE; Beumer TL; van Hasselt JG; Lipplaa A; Karger LB; Kleinloog HD; Freijer JI; de Kam ML; van Gerven JM
    Br J Clin Pharmacol; 2012 Jul; 74(1):42-53. PubMed ID: 22680341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.
    Schwope DM; Bosker WM; Ramaekers JG; Gorelick DA; Huestis MA
    J Anal Toxicol; 2012 Jul; 36(6):405-12. PubMed ID: 22589524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.